We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Eagle Pharmaceuticals has made good on a threat to sue the FDA over its refusal to grant the company full exclusivity rights for its cancer drug Bendeka. Read More
Public Citizen is suing the FDA for withholding details about members of its advisory committees and panels, contending that this information could expose potentially problematic relationships with industry. Read More
Members of the Senate Special Committee on Aging took Valeant Pharmaceuticals’ International officials to task over what they called the company’s practice of buying drugs with no generic competition and “jacking up” the prices. Read More
As expected, Pfizer will pay $784.6 million to settle Justice Department allegations that a subsidiary deliberately reported inflated prices to Medicaid for two drugs. Read More
The FDA has extended the PDUFA date of Dynavax’s investigational hepatitis B vaccine Heplisav-B by three months to review new data in the company’s resubmitted BLA. Read More